{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:47:53Z","timestamp":1782380873190,"version":"3.54.5"},"reference-count":61,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.3724\/abbs.2026060","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T02:04:44Z","timestamp":1775527484000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["The USP46-MCM7-RAD51 axis confers oxaliplatin resistance in colon cancer by augmenting homologous recombination repair capacity"],"prefix":"10.3724","author":[{"given":"Changlei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taifu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/cancers16081530","volume":"16","author":"Roshandel G","year":"2024","unstructured":"Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers, 2024, 16: 1530.","journal-title":"Cancers"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1186\/s12967-024-05467-2","volume":"22","author":"Lund-Andersen C","year":"2024","unstructured":"Lund-Andersen C, Torgunrud A, Kanduri C, Dagenborg VJ, Fr\u00f8ysnes IS, Larsen MM, Davidson B. Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. J Transl Med, 2024, 22: 646.","journal-title":"J Transl Med"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41392-025-02129-7","volume":"10","author":"Nussinov R","year":"2025","unstructured":"Nussinov R, Yavuz BR, Jang H. Molecular principles underlying aggressive cancers. Sig Transduct Target Ther, 2025, 10: 42.","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/molecules21070965","volume":"21","author":"Du B","year":"2016","unstructured":"Du B, Shim J. Targeting epithelial\u2013mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules, 2016, 21: 965.","journal-title":"Molecules"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05838-7","volume":"616","author":"Debaugnies M","year":"2023","unstructured":"Debaugnies M, Rodr\u00edguez-Acebes S, Blondeau J, Parent MA, Zocco M, Song Y, de Maertelaer V. RHOJ controls EMT-associated resistance to chemotherapy. Nature, 2023, 616: 168-175.","journal-title":"Nature"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"Liu F","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer, 2024, 23: 148.","journal-title":"Mol Cancer"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13046-024-03056-1","volume":"43","author":"Zhang R","year":"2024","unstructured":"Zhang R, Zhang D, Han F, Song X, Zhang Y, Zhang J, Zhu Q. The deubiquitinase USP7 and E3 ligase TRIM21 regulate vasculogenic mimicry and malignant progression of RMS by balancing SNAI2 homeostasis. J Exp Clin Cancer Res, 2024, 43: 135.","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","volume":"82","author":"Lange SM","year":"2022","unstructured":"Lange SM, Armstrong LA, Kulathu Y. Deubiquitinases: from mechanisms to their inhibition by small molecules. Mol Cell, 2022, 82: 15-29.","journal-title":"Mol Cell"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00018-024-05187-2","volume":"81","author":"Karapurkar JK","year":"2024","unstructured":"Karapurkar JK, Colaco JC, Suresh B, Tyagi A, Woo SH, Jo WJ, Ko N. USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells. Cell Mol Life Sci, 2024, 81: 145.","journal-title":"Cell Mol Life Sci"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"e39084","DOI":"10.1371\/journal.pone.0039084","volume":"7","author":"Imai S","year":"2012","unstructured":"Imai S, Mamiya T, Tsukada A, Sakai Y, Mouri A, Nabeshima T, Ebihara S. Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system. PLoS One, 2012, 7: e39084.","journal-title":"PLoS One"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.30773\/pi.2018.10.02","volume":"16","author":"Boo YJ","year":"2019","unstructured":"Boo YJ, Park CI, Kim HW, Kim SJ, Kang JI. Possible association of the ubiquitin-specific peptidase 46 gene (USP46) with affective temperamental traits in healthy korean volunteers. Psychiatry Investig, 2019, 16: 87-92.","journal-title":"Psychiatry Investig"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"1055067","DOI":"10.3389\/fcell.2022.1055067","volume":"10","author":"Corno C","year":"2022","unstructured":"Corno C, D\u2019Arcy P, Bagnoli M, Paolini B, Costantino M, Carenini N, Corna E. The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis. Front Cell Dev Biol, 2022, 10: 1055067.","journal-title":"Front Cell Dev Biol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"167011","DOI":"10.1016\/j.bbadis.2023.167011","volume":"1870","author":"Gao S","year":"2024","unstructured":"Gao S, Wang Y, Xu Y, Liu L, Liu S. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis. Biochim Biophys Acta Mol Basis Dis, 2024, 1870: 167011.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bbrc.2019.09.036","volume":"519","author":"Gui D","year":"2019","unstructured":"Gui D, Peng W, Jiang W, Huang G, Liu G, Ye Z, Wang Y. Ubiquitin-specific peptidase 46 (USP46) suppresses renal cell carcinoma tumorigenesis through AKT pathway inactivation. Biochem Biophys Res Commun, 2019, 519: 689-696.","journal-title":"Biochem Biophys Res Commun"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"112646","DOI":"10.1016\/j.yexcr.2021.112646","volume":"405","author":"Qiu Y","year":"2021","unstructured":"Qiu Y, Huang D, Sheng Y, Huang J, Li N, Zhang S, Hong Z. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1. Exp Cell Res, 2021, 405: 112646.","journal-title":"Exp Cell Res"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"115149","DOI":"10.1016\/j.ab.2023.115149","volume":"671","author":"Osmano\u011fullar\u0131 SC","year":"2023","unstructured":"Osmano\u011fullar\u0131 SC, Forough M, Persil \u00c7etinkol \u00d6, Arslan Udum Y, Toppare L. Electrochemical detection of Oxaliplatin induced DNA damage in G-quadruplex structures. Anal Biochem, 2023, 671: 115149.","journal-title":"Anal Biochem"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1021\/acschembio.2c00399","volume":"17","author":"Pigg HC","year":"2022","unstructured":"Pigg HC, Yglesias MV, Sutton EC, McDevitt CE, Shaw M, DeRose VJ. Time-dependent studies of oxaliplatin and other nucleolar stress-inducing Pt(II) derivatives. ACS Chem Biol, 2022, 17: 2262-2271.","journal-title":"ACS Chem Biol"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"e161941","DOI":"10.1172\/JCI161941","volume":"134","author":"Kaur E","year":"2024","unstructured":"Kaur E, Agrawal R, Arun R, Madhavan V, Srivastava V, Kumar D, Rath PP. Small molecules that disrupt RAD54-BLM interaction hamper tumor proliferation in colon cancer chemoresistance models. J Clin Invest, 2024, 134: e161941.","journal-title":"J Clin Invest"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.21873\/anticanres.16241","volume":"43","author":"Voutsadakis IA","year":"2023","unstructured":"Voutsadakis IA, Stravodimou A. Homologous recombination defects and mutations in DNA damage response (DDR) genes besides                         BRCA1 and                         BRCA2 as breast cancer biomarkers for PARP inhibitors and other DDR targeting therapies. Anticancer Res, 2023, 43: 967-981.","journal-title":"Anticancer Res"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"e2416590","DOI":"10.1002\/advs.202416590","volume":"12","author":"Liu H","year":"2025","unstructured":"Liu H, Feng J, Pan T, Zhang P, Ye L, Jiang Z, Zhou Z. Nuclear-localized BCKDK facilitates homologous recombination repair to support breast cancer progression and therapy resistance. Adv Sci, 2025, 12: e2416590.","journal-title":"Adv Sci"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3390\/cancers13091998","volume":"13","author":"Zheng W","year":"2021","unstructured":"Zheng W, Chen Q, Liu H, Hu S, Zhou Y, Bai Y, Zhang J. CD81 enhances radioresistance of glioblastoma by promoting nuclear translocation of Rad51. Cancers, 2021, 13: 1998.","journal-title":"Cancers"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"188597","DOI":"10.1016\/j.bbcan.2021.188597","volume":"1876","author":"Demeyer A","year":"2021","unstructured":"Demeyer A, Benhelli-Mokrani H, Ch\u00e9nais B, Weigel P, Fleury F. Inhibiting homologous recombination by targeting RAD51 protein. Biochim Biophys Acta Rev Cancer, 2021, 1876: 188597.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1158\/0008-5472.CAN-21-2409","volume":"82","author":"Pellegrino B","year":"2022","unstructured":"Pellegrino B, Herencia-Ropero A, Llop-Guevara A, Pedretti F, Moles-Fern\u00e1ndez A, Viaplana C, Villacampa G. Preclinical                         in vivo validation of the RAD51 test for identification of homologous recombination-deficient tumors and patient stratification. Cancer Res, 2022, 82: 1646-1657.","journal-title":"Cancer Res"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"100585","DOI":"10.1016\/j.esmoop.2022.100585","volume":"7","author":"Capoluongo ED","year":"2022","unstructured":"Capoluongo ED, Pellegrino B, Arenare L, Califano D, Scambia G, Beltrame L, Serra V. Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A\/MaNGO-OV2 trial. ESMO Open, 2022, 7: 100585.","journal-title":"ESMO Open"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"e16863","DOI":"10.15252\/emmm.202216863","volume":"15","author":"Planas-Paz L","year":"2023","unstructured":"Planas-Paz L, Pliego-Mendieta A, Hagedorn C, Aguilera-Garcia D, Haberecker M, Arnold F, Herzog M. Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. EMBO Mol Med, 2023, 15: e16863.","journal-title":"EMBO Mol Med"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"EMMM202216235","DOI":"10.15252\/emmm.202216235","volume":"15","author":"Wang LM","year":"2023","unstructured":"Wang LM, Wang P, Chen XM, Yang H, Song SS, Song Z, Jia L. Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO Mol Med, 2023, 15: EMMM202216235.","journal-title":"EMBO Mol Med"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"116888","DOI":"10.1016\/j.bcp.2025.116888","volume":"236","author":"Wu Y","year":"2025","unstructured":"Wu Y, Lin B, Xie Z, Huang J, Qiu Y, Chen X, Hong Z. SUMOylation of RAD51 upregulates GOLPH3 expression and promotes cisplatin resistance in colon cancer cells by Sp1 transcriptional activity. Biochem Pharmacol, 2025, 236: 116888.","journal-title":"Biochem Pharmacol"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.3390\/ijms23158338","volume":"23","author":"Schipani F","year":"2022","unstructured":"Schipani F, Manerba M, Marotta R, Poppi L, Gennari A, Rinaldi F, Armirotti A. The mechanistic understanding of RAD51 defibrillation: a critical step in BRCA2-Mediated DNA repair by homologous recombination. Int J Mol Sci, 2022, 23: 8338.","journal-title":"Int J Mol Sci"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1016\/j.molcel.2022.07.010","volume":"82","author":"Bhowmick R","year":"2022","unstructured":"Bhowmick R, Lerdrup M, Gadi SA, Rossetti GG, Singh MI, Liu Y, Halazonetis TD. RAD51 protects human cells from transcription-replication conflicts. Mol Cell, 2022, 82: 3366-3381.e9.","journal-title":"Mol Cell"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1158\/0008-5472.CAN-13-3220","volume":"74","author":"Mason JM","year":"2014","unstructured":"Mason JM, Logan HL, Budke B, Wu M, Pawlowski M, Weichselbaum RR, Kozikowski AP. The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. Cancer Res, 2014, 74: 3546-3555.","journal-title":"Cancer Res"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1093\/nar\/gks353","volume":"40","author":"Budke B","year":"2012","unstructured":"Budke B, Logan HL, Kalin JH, Zelivianskaia AS, Cameron McGuire W, Miller LL, Stark JM. RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Res, 2012, 40: 7347-7357.","journal-title":"Nucleic Acids Res"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"2509529","DOI":"10.1155\/2020\/2509529","volume":"2020","author":"Wang W","year":"2020","unstructured":"Wang W, Chen M, Xu H, Lv D, Zhou S, Yang H, Linnebacher M. USP46 inhibits cell proliferation in lung cancer through PHLPP1\/AKT pathway. Biomed Res Int, 2020, 2020: 2509529.","journal-title":"Biomed Res Int"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/cancers14010030","volume":"14","author":"Kiran S","year":"2021","unstructured":"Kiran S, Wilson B, Saha S, Graff JA, Dutta A. HPVE6-USP46 mediated Cdt2 stabilization reduces Set8 mediated H4K20-Methylation to induce gene expression changes. Cancers, 2021, 14: 30.","journal-title":"Cancers"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/cbin.11937","volume":"47","author":"Ke L","year":"2023","unstructured":"Ke L, Jia Z, Gao W, Luo L. Ubiquitin specific protease 46 potentiates triple negative breast cancer development by stabilizing PGAM1-mediated glycolysis. Cell Biol Int, 2023, 47: 41-51.","journal-title":"Cell Biol Int"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1038\/s41467-023-41836-z","volume":"14","author":"Ng VH","year":"2023","unstructured":"Ng VH, Spencer Z, Neitzel LR, Nayak A, Loberg MA, Shen C, Kassel SN. The USP46 complex deubiquitylates LRP6 to promote Wnt\/\u03b2-catenin signaling. Nat Commun, 2023, 14: 6173.","journal-title":"Nat Commun"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"24992","DOI":"10.18632\/oncotarget.25167","volume":"9","author":"McClurg UL","year":"2018","unstructured":"McClurg UL, Azizyan M, Dransfield DT, Namdev N, Chit NCTH, Nakjang S, Robson CN. The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival. Oncotarget, 2018, 9: 24992-25007.","journal-title":"Oncotarget"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1158\/0008-5472.CAN-22-1535","volume":"82","author":"Foo TK","year":"2022","unstructured":"Foo TK, Xia B. BRCA1-Dependent and independent recruitment of PALB2-BRCA2-RAD51 in the DNA damage response and cancer. Cancer Res, 2022, 82: 3191-3197.","journal-title":"Cancer Res"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1038\/s41467-023-42850-x","volume":"14","author":"Tao L","year":"2023","unstructured":"Tao L, Zhou Y, Pan X, Luo Y, Qiu J, Zhou X, Chen Z. Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1\/2 and RAD51. Nat Commun, 2023, 14: 7430.","journal-title":"Nat Commun"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"15848","DOI":"10.1073\/pnas.0808046105","volume":"105","author":"Jayathilaka K","year":"2008","unstructured":"Jayathilaka K, Sheridan SD, Bold TD, Bochenska K, Logan HL, Weichselbaum RR, Bishop DK. A chemical compound that stimulates the human homologous recombination protein RAD51. Proc Natl Acad Sci USA, 2008, 105: 15848-15853.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"e13059","DOI":"10.1111\/cpr.13059","volume":"54","author":"Lee AR","year":"2021","unstructured":"Lee AR, Park JH, Shim SH, Hong K, La H, Park KS, Lee DR. Genome stabilization by RAD51-stimulatory compound 1 enhances efficiency of somatic cell nuclear transfer-mediated reprogramming and full-term development of cloned mouse embryos. Cell Prolif, 2021, 54: e13059.","journal-title":"Cell Prolif"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"8857","DOI":"10.1038\/s41598-025-92925-6","volume":"15","author":"Gao M","year":"2025","unstructured":"Gao M, Wu Y, Zhang L, Zhou Y, Liu H, Zhang W, Wang S. YTHDC1 negatively regulates UBE3A to influence RAD51 ubiquitination and inhibit apoptosis in colorectal cancer cells. Sci Rep, 2025, 15: 8857.","journal-title":"Sci Rep"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-021-00510-w","volume":"6","author":"Kang JW","year":"2021","unstructured":"Kang JW, Zhan Z, Ji G, Sang Y, Zhou D, Li Y, Feng H. PUMA facilitates EMI1-promoted cytoplasmic Rad51 ubiquitination and inhibits DNA repair in stem and progenitor cells. Sig Transduct Target Ther, 2021, 6: 129.","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"41776","DOI":"10.1038\/srep41776","volume":"7","author":"Liang Z","year":"2017","unstructured":"Liang Z, Li W, Liu J, Li J, He F, Jiang Y, Yang L. Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells. Sci Rep, 2017, 7: 41776.","journal-title":"Sci Rep"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.biopha.2017.06.024","volume":"93","author":"Guan Y","year":"2017","unstructured":"Guan Y, Yang D, Nong S, Ni J, Hu C, Li J, Zhu J. Breviscapine (BVP) inhibits prostate cancer progression through damaging DNA by minichromosome maintenance protein-7 (MCM-7) modulation. Biomed Pharmacother, 2017, 93: 103-116.","journal-title":"Biomed Pharmacother"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41419-020-2704-9","volume":"11","author":"Gastl B","year":"2020","unstructured":"Gastl B, Klotz-Noack K, Klinger B, Ispasanie S, Salib KHF, Zuber J, Mamlouk S. Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe. Cell Death Dis, 2020, 11: 499.","journal-title":"Cell Death Dis"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/s41388-024-03015-2","volume":"43","author":"Wei Y","year":"2024","unstructured":"Wei Y, Chen Z, Li Y, Song K. The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer. Oncogene, 2024, 43: 1565-1578.","journal-title":"Oncogene"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"e60371","DOI":"10.7554\/eLife.60371","volume":"9","author":"Deegan TD","year":"2020","unstructured":"Deegan TD, Mukherjee PP, Fujisawa R, Polo Rivera C, Labib K. CMG helicase disassembly is controlled by replication fork DNA, replisome components and a ubiquitin threshold. eLife, 2020, 9: e60371.","journal-title":"eLife"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s11427-023-2600-0","volume":"68","author":"Duan H","year":"2025","unstructured":"Duan H, Wang S, Shu WJ, Tong Y, Long HZ, Li G, Du HN. SETD3-mediated histidine methylation of MCM7 regulates DNA replication by facilitating chromatin loading of MCM. Sci China Life Sci, 2025, 68: 793-808.","journal-title":"Sci China Life Sci"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1038\/s44318-024-00161-x","volume":"43","author":"Polo Rivera C","year":"2024","unstructured":"Polo Rivera C, Deegan TD, Labib KPM. CMG helicase disassembly is essential and driven by two pathways in budding yeast. EMBO J, 2024, 43: 3818-3845.","journal-title":"EMBO J"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"gkaf530","DOI":"10.1093\/nar\/gkaf530","volume":"53","author":"Poovathumkadavil D","year":"2025","unstructured":"Poovathumkadavil D, Reynolds-Winczura A, Skagia A, Passaretti P, Sadurni MM, Kingsley G, Leitner A. CDK-driven phosphorylation of TRAIP is essential for mitotic replisome disassembly and MiDAS. Nucleic Acids Res, 2025, 53: gkaf530.","journal-title":"Nucleic Acids Res"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1016\/j.celrep.2017.03.020","volume":"18","author":"Maric M","year":"2017","unstructured":"Maric M, Mukherjee P, Tatham MH, Hay R, Labib K. Ufd1-Npl4 recruit Cdc48 for disassembly of ubiquitylated CMG helicase at the end of chromosome replication. Cell Rep, 2017, 18: 3033-3042.","journal-title":"Cell Rep"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1038\/s41467-025-59770-7","volume":"16","author":"Bolhuis DL","year":"2025","unstructured":"Bolhuis DL, Fleifel D, Bonacci T, Wang X, Mouery BL, Cook JG, Brown NG. USP37 prevents unscheduled replisome unloading through MCM complex deubiquitination. Nat Commun, 2025, 16: 4575.","journal-title":"Nat Commun"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"122912","DOI":"10.1016\/j.lfs.2024.122912","volume":"353","author":"Sun Q","year":"2024","unstructured":"Sun Q, Sui Y, Li S, Zhou R, Fu Z, Luo J, Zhao W. RNF8-mediated multi-ubiquitination of MCM7: linking disassembly of the CMG helicase with DNA damage response in human cells. Life Sci, 2024, 353: 122912.","journal-title":"Life Sci"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1093\/nar\/gkab1174","volume":"49","author":"Zhou H","year":"2021","unstructured":"Zhou H, Zaher MS, Walter JC, Brown A. Structure of CRL2Lrr1, the E3 ubiquitin ligase that promotes DNA replication termination in vertebrates. Nucleic Acids Res, 2021, 49: 13194-13206.","journal-title":"Nucleic Acids Res"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s42003-024-06999-5","volume":"7","author":"Cao J","year":"2024","unstructured":"Cao J, Wu S, Zhao S, Wang L, Wu Y, Song L, Sun C. USP24 promotes autophagy-dependent ferroptosis in hepatocellular carcinoma by reducing the K48-linked ubiquitination of Beclin1. Commun Biol, 2024, 7: 1279.","journal-title":"Commun Biol"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41418-024-01287-5","volume":"31","author":"Feng P","year":"2024","unstructured":"Feng P, Wang Y, Liu N, Chen Y, Hu Y, Huang Z, Liu Y. High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma. Cell Death Differ, 2024, 31: 683-696.","journal-title":"Cell Death Differ"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41419-023-05871-4","volume":"14","author":"Liu X","year":"2023","unstructured":"Liu X, Xu J, shen B, Xu J, Jiang J. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2\/TGF\u03b2 signaling pathway. Cell Death Dis, 2023, 14: 362.","journal-title":"Cell Death Dis"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"e202306013","DOI":"10.1083\/jcb.202306013","volume":"223","author":"Endo A","year":"2024","unstructured":"Endo A, Fukushima T, Takahashi C, Tsuchiya H, Ohtake F, Ono S, Ly T. USP8 prevents aberrant NF-\u03baB and Nrf2 activation by counteracting ubiquitin signals from endosomes. J Cell Biol, 2024, 223: e202306013.","journal-title":"J Cell Biol"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1128\/MCB.00434-16","volume":"36","author":"Fullbright G","year":"2016","unstructured":"Fullbright G, Rycenga HB, Gruber JD, Long DT. p97 promotes a conserved mechanism of helicase unloading during DNA cross-link repair. Mol Cell Biol, 2016, 36: 2983-2994.","journal-title":"Mol Cell Biol"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1134\/S0006297918010091","volume":"83","author":"Huang J","year":"2018","unstructured":"Huang J, Luo HL, Pan H, Qiu C, Hao TF, Zhu ZM. Interaction between RAD51 and MCM complex is essential for RAD51 foci forming in colon cancer HCT116 cells. Biochem Moscow, 2018, 83: 69-75.","journal-title":"Biochem Moscow"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"116408","DOI":"10.1016\/j.biopha.2024.116408","volume":"173","author":"Tian Y","year":"2024","unstructured":"Tian Y, Zhou Y, Chen F, Qian S, Hu X, Zhang B, Liu Q. Research progress in MCM family: focus on the tumor treatment resistance. Biomed Pharmacother, 2024, 173: 116408.","journal-title":"Biomed Pharmacother"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/54672B36F952409095B4595DAC691CF4","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026060","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/54672B36F952409095B4595DAC691CF4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:13:10Z","timestamp":1782378790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":61,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026060","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}